Last reviewed · How we verify

NCT05604404

Effects of Head-of-Bed on Intracranial Pressure

Withdrawn NA Last updated 16 April 2026
What this trial tests

NA trial testing Supine in Subarachnoid Hemorrhage, Aneurysmal. Withdrawn.

Timeline
24 April 2023
Primary endpoint
13 April 2026
13 April 2026

Quick facts

Lead sponsorMilton S. Hershey Medical Center
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date24 April 2023
Primary completion13 April 2026
Estimated completion13 April 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Milton S. Hershey Medical Center

Who can join

18 and older, any sex, with Subarachnoid Hemorrhage, Aneurysmal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate how pressure inside the skull responds to position changes in patients with brain bleeds.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Supine

Trials testing the same drug.

Other recruiting trials for Subarachnoid Hemorrhage, Aneurysmal

Currently open trials in the same condition.

Other Milton S. Hershey Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604404.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing